Innovaro Inc Ordinary Shares INV 深 沪
等待开盘 12-18 09:30:00 美东时间
4.76
-0.130
-2.66%
华盛通- 最 高5.08
- 今 开4.97
- 成交量 142.49万股
- 最 低 4.65
- 昨 收 4.89
- 总市值 2.97亿
- 52周最高 13.90
- 市盈率 静 --
- 换手率 2.28%
- 52周最低 2.36
- 委 比 8.08%
- 总股本 6247.20万
- 历史最高 18.75
- 量 比 0.76
- 振 幅 8.79%
- 历史最低 2.36
- 每 手 1
- 风险率 3.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多11 Financials Stocks Moving In Monday's Intraday Session
Gainers Coincheck Group (NASDAQ:CNCK) stock moved upwards by 37.7% to $4.46 du...
12-02 01:05
美股牛股 | 绩优股集体大爆发！柯尔百货暴涨超42%，连续两季度上调业绩指引；Symbotic大涨近40%
绩优股集体大爆发！柯尔百货暴涨超42%，连续两季度上调业绩指引；Symbotic大涨近40%，年内涨幅达226%>>
11-26 16:15
美股牛股 | 社区电商平台WeShop上市两日股价翻倍！锂矿公司SGML大涨逾32%
社区电商平台WeShop大涨30%！上市两日股价翻倍；强劲需求驱动近期锂价上涨，锂矿公司SGML隔夜飙涨逾32%>>
11-18 17:39
Innventure Strengthens Corporate Governance with Appointment of Bruce Brown as Lead Independent Director
Innventure, Inc. announced the appointment of Bruce Brown as its first Lead Independent Director to strengthen corporate governance and oversight as the company scales its technology-driven businesses. Brown, with extensive experience in innovation and technology, will assist in developing Board agendas, liaise between the Board Chairman and independent directors, and communicate with major stockholders. He has served as an independent director s...
11-18 13:00
Innventure Q3 EPS $(0.51) Misses $(0.09) Estimate, Sales $534.000K Miss $1.963M Estimate
Innventure (NASDAQ:INV) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.09) by 466.67 percent. This is a 45.74 percent increase over losses of $(0.94) per share from the
11-14 05:19
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
What's Next: Innventure's Earnings Preview
Innventure (NASDAQ:INV) will release its quarterly earnings report on Thursday,...
11-13 03:04
KBR, Inc. (KBR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against KBR, In...
10-23 03:28
Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce
Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff.
10-23 00:07
市值160亿，中国电商SaaS ERP龙头登陆港交所
原标题：市值160亿，中国电商SaaS ERP龙头登陆港交所 来源：直通IPO 四次闯关，中国最 大电商SaaS ERP提供商终于登陆港股市场。 10月21日...
10-23 00:02
